Hyundai Pharm (004310) — Strategic Asset Allocation Index
Hyundai Pharm (004310) has a Strategic Asset Allocation Index of 38.7% as of November 2013. Strategic assets (PP&E of ₩33.35 Billion plus long-term investments of ₩5.83 Billion) total ₩39.18 Billion, measured against net assets of ₩101.21 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Hyundai Pharm Strategic Asset Allocation Index (2010–2013)
This chart shows how Hyundai Pharm's Strategic Asset Allocation Index has evolved across 4 annual periods from 2010 to 2013. As of November 2013, the index stands at 38.7%, representing strategic assets of ₩39.18 Billion against net assets of ₩101.21 Billion KRW. Explore 004310 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Hyundai Pharm (2010–2013)
The table below presents the year-by-year Strategic Asset Allocation Index for Hyundai Pharm from 2010 to 2013, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 004310 market cap overview.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2013 | 38.7% | ₩39.18 Billion | ₩33.35 Billion | ₩5.83 Billion | ₩101.21 Billion | ▲ +0.0 pp |
| 2012 | 38.7% | ₩38.57 Billion | ₩33.10 Billion | ₩5.47 Billion | ₩99.69 Billion | ▼ -4.0 pp |
| 2011 | 42.7% | ₩44.52 Billion | ₩40.73 Billion | ₩3.80 Billion | ₩104.32 Billion | ▼ -11.9 pp |
| 2010 | 54.6% | ₩50.49 Billion | ₩43.17 Billion | ₩7.32 Billion | ₩92.50 Billion | — |